Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer
Christoph Ausch(Ludwig Boltzmann Institute for Cardiovascular Research), R Schiessel(Ludwig Boltzmann Institute for Cardiovascular Research), Thomas Bauernhofer, Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), E Ogris(Ludwig Boltzmann Institute for Cardiovascular Research), Nadia Dandachi(Medical University of Graz), W Hinterberger(Ludwig Boltzmann Institute for Cardiovascular Research), Klaus Huber(Universität für Weiterbildung Krems), Marija Balić(University of Pittsburgh), Stephan Braun(Amgen (Switzerland))
Cited by 2
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273